SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus

Infection Control and Hospital Epidemiology

Volumn 31, Issue 3, 2010, Pages 203-232

  Henderson, David K ^a   Dembry, Louise ^b   Fishman, Neil O ^c   Grady, Christine ^d   Lundstrom, Tammy ^e   Palmore, Tara N ^d   Sepkowitz, Kent A ^f   Weber, David J ^g  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e PROVIDENCE HOSPITAL   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOODBORNE BACTERIUM; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; VIRUS LOAD; VIRUS TRANSMISSION;

HEALTH PERSONNEL; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT;

EID: 77249116214     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/650298     Document Type: Review

References (154)

1. Reitsma AM, Closen ML, Cunningham M, et al. Infected physicians and invasive procedures: safe practice management. Clin Infect Dis 2005; 40:1665-1672.
2. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for infection control in dental health-care settings-2003. MMWR Recomm Rep 2003; 52:1-61.
3. Centers for Disease Control and Prevention. Possible transmission of human immunodeficiency virus to a patient during an invasive dental procedure. MMWR Morb Mortal Wkly Rep 1990; 39:489-493.
4. Centers for Disease Control and Prevention. Update: Transmission of HIV infection during an invasive dental procedure-Florida. MMWR Morb Mortal Wkly Rep 1991; 40:21-33.
5. Centers for Disease Control and Prevention. Update: investigations of patients who have been treated by HIV-infected health care workers. MMWR Morb Mortal Wkly Rep 1992; 41:344-346.
6. Ciesielski C, Marianos D, Ou C-Y, et al. Transmission of human immunodeficiency virus in a dental practice. Ann Intern Med 1992; 116: 798-805.
7. Ciesielski CA, Bell DM, Marianos DW. Transmission of HIV from infected health-care workers to patients. AIDS 1991; 5:S93-S97.
8. Ou CY, Ciesielski CA, Myers G, et al. Molecular epidemiology of HIV transmission in a dental practice. Science 1992; 256:1165-2271.
9. Rhame FS, Pitt H, Tapper ML, et al. Position paper: The HIV-infected health care worker. Infect Control Hosp Epidemiol 1990; 11:647-656.
10. Henderson DK, The AIDS/Tuberculosis Subcommittee of the Society for Healthcare Epidemiology of America. Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. AIDS/TB Committee of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1997; 18:349-363.
11. Bell D, Shapiro CN, Chamberland ME, CA. C. Preventing bloodborne pathogen transmission from health-care workers to patients: the CDC perspective. Surg Clin North Am 1995; 75:1189-1203.
12. Harpaz R, Von Seidlein L, Averhoff FM, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996; 334:549-554.
13. Johnston B, Langille D, LeBlanc J, et al. Transmission of hepatitis B related to orthopedic surgery [abstract]. Infect Control Hosp Epidemiol 1994; 15:352.
14. Incident Investigation Teams and others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997; 336:178-184.
15. Laurenson IF, Jones DG, Hallam NF, Saunders CJ, Fraser DM, Carman WF. Transmission of hepatitis B virus from a vaccinated healthcare worker. J Hosp Infect 2007; 66:393-394.
16. Hepatitis B Outbreak Investigation Team. An outbreak of hepatitis B associated with reusable subdermal electroencephalogram electrodes. CMAJ 2000; 162:1127-1131.
17. Alter MJ. Healthcare should not be a vehicle for transmission of hepatitis C virus. J Hepatol 2008; 48:2-4.
18. Bosch X. Hepatitis C outbreak astounds Spain. Lancet April 8, 2005.
19. Brown P. Surgeon infects patient with hepatitis C. BMJ (Clinical research ed.) 1999; 319(7219):1219.
20. Cody SH, Nainan OV, Garfein RS, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002; 162:345-350.
21. Duckworth GJ, Heptonstall J, Aitken C. Transmission of hepatitis C virus from a surgeon to a patient. The Incident Control Team. Commun Dis Public Health 1999; 2:188-192.
22. Esteban JI, Gomez J, Martell M, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334:555-560.
23. Public Health Laboratory Service. Hepatitis C transmission fromhealth care worker to patient. Commun Dis Rep CDR Wkly 1995; 5:121.
24. Public Health Laboratory Service. Transmission of hepatitis C virus from surgeon to patient prompts lookback. Commun Dis Rep CDR Wkly 1999; 9:387.
25. Public Health Laboratory Service. Hepatitis C lookback exercise. Commun Dis Rep CDR Wkly 2000; 10:203, 206.
26. Public Health Laboratory Service. Two hepatitis C lookback exercises- national and in London. Commun Dis Rep CDR Wkly 2000; 10:125, 128.
27. Hepatitis C lookback in two trusts in the south of England. Public Health Laboratory Service, 2002. http://www.phls.org.uk/publications/cdr/PDFfiles/ 2001/cdr2101.pdf. Accessed November 14, 2002.
28. Ross RS, Viazov S, Roggendorf M. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopedic surgeon to a patient. J Med Virol 2002; 66:461-467.
29. Ross RS, Viazov S, Thormahlen M, et al. Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7year retrospective investigation. Arch Intern Med 2002; 162:805-810.
30. Williams IT, Perz JF, Bell BP. Viral hepatitis transmission in ambulatory health care settings. Clin Infect Dis 2004; 38:1592-1598.
31. Mawdsley J, Teo CG, Kyi M, Anderson M. Anesthetist to patient transmission of hepatitis C virus associated with non exposure-prone procedures. J Med Virol 2005; 75:399-401. (Pubitemid 40175904)
32. Shemer-Avni Y, Cohen M, Keren-Naus A, et al. Iatrogenic transmission of hepatitis C virus (HCV) by an anesthesiologist: comparative molecular analysis of the HCV-E1 and HCV-E2 hypervariable regions. Clin Infect Dis 2007; 45:e32-e38.
33. Public Health Laboratory Service. New guidelines on post exposure prophylaxis for HIV. Commun Dis Rep CDR Wkly 2000; 10:311, 314.
34. Pugliese G. Data lacking for postexposure prophylaxis with immuneserum globulin following HCV exposure. Infect Control Hosp Epidemiol 1994; 15:212.
35. Pugliese G, Favero MS. Healthcare Worker-to-Patient Transmission of HCV in the UK. Infect Control Hosp Epidemiol 2000; 21:619.
36. Ross RS, Viazov S, Gross T, Hofmann F, Seipp HM, Roggendorf M. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients. N Engl J Med 2000; 343:1851-1854.
37. Sehulster L, Taylor J, Hendricks K, VanEgdom M, Whitely S, Manning S. Hepatitis C outbreak linked to narcotic tampering in an ambulatory surgical center. In: Proceedings of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997. Washington, D.C.: American Society for Microbiology; 1997:293.
38. Centers for Disease Control and Prevention. Transmission of hepatitis C virus infection associated with home infusion therapy for hemophilia. MMWR Morb Mortal Wkly Rep 1997; 46:597-599.
39. Williams IT, Perz JF, Bell BP. Hepatitis C virus transmission fromhealthcare workers to patients in the United States [abstract]. J Clin Virol 2006; 36:S43-S44.
40. Bosch X. Newspaper apportions blame in Spanish hepatitis C scandal. Lancet 2000; 355:818.
41. Astagneau P, Lot F, Bouvet E, et al. Lookback investigation of patients potentially exposed to HIV type 1 after a nurse-to-patient transmission. Am J Infect Control 2002; 30:242-245.
42. Blanchard A, Ferris S, Chamaret S, Guetard D, Montagnier L.Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients. J Virol 1998; 72:4537-4540.
43. Bosch X. Second case of doctor-to-patient HIV transmission. Lancet Infect Dis 2003; 3:261.
44. Goujon CP, Schneider VM, Grofti J, et al. Phylogenetic analyses indicate an atypical nurse-to-patient transmission of human immunodeficiency virus type 1. J Virol 2000; 74:2525-2532.
45. Lot F, Seguier JC, Fegueux S, et al. Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med 1999; 130: 1-6.
46. Armstrong FP, Miner JC, Wolfe WH. Investigation of a health care worker with symptomatic human immunodeficiency virus infection: an epidemiological approach. Military Medicine 1987; 152:414-418.
47. Centers for Disease Control and Prevention. Update: Investigations of persons treated by HIV-infected health-care workers-United States. MMWR Morb Mortal Wkly Rep 1993; 42:329-331.
48. Danila RN, MacDonald KL, Rhame FS, et al. A look-back investigation of patients of an HIV-infected physician: public health implications. N Engl J Med 1991; 325:1406-1411.
49. Dickinson GM, Morhart RE, Klimas NG, Bandea CI, Laracuente JM, Bisno AL. Absence of HIV transmission from an infected dentist to his patients: an epidemiologic and DNA sequence analysis. JAMA 1993; 269: 1802-1806.
50. Mishu B, Schaffner W, Horan JM, Wood LH, Hutcheson RH, McNabb PC. A surgeon with AIDS: lack of evidence of transmission to patients. JAMA 1990; 264:467-470.
51. Porter JD, Cruickshank JG, Gentle PH, Robinson RG, Gill ON. Management of patients treated by surgeon with HIV infection. Lancet 1990; 335:113-114.
52. Pretty IA, Anderson GS, Sweet DJ. Human bites and the risk of human immunodeficiency virus transmission. Am J Forensic Med Pathol 1999; 20:232-239.
53. Robert LM, Chamberland ME, Cleveland JL, et al. Investigations of patients of health care workers infected with HIV: the Centers for Disease Control and Prevention database. Ann Intern Med 1995; 122:653-657.
54. Rogers AS, Froggatt JW, Townsend T, et al. Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA 1993; 269:1795-1801.
55. Sacks JJ. AIDS in a surgeon. N Engl J Med 1985; 313:1017-1018.
56. Mascioli SR. More on AIDS in a surgeon. N Engl J Med 1986; 314:1190.
57. von Reyn CF, Gilbert TT, Shaw FE, Jr., Parsonnet KC, Abramson JE, Smith MG. Absence of HIV transmission from an infected orthopedic surgeon: a 13-year look-back study. JAMA 1993; 269:1807-1811.
58. Chant K, Lowe D, Rubin G, et al. Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet 1993; 342:1548-1549.
59. Alter HJ. Hepatitis B and the health worker: prospective studies in perspective. Ann Intern Med 1976; 85:971-972.
60. Alter HJ, Chalmers TC. The HBsAg Positive health worker revisited. Hepatology 1981; 1:467-1370
61. Alter HJ, Chalmers TC, Freeman BM, et al. Health-care workers positive for hepatitis B surface antigen: are their contacts at risk? N Engl J Med 1975; 292:454-457.
62. Meyers J, Stamm W, Kwerr M, Counts GW. Lack of transmission of hepatitis B after surgical exposure. JAMA 1978; 240:1725-1727.
63. Williams S, Pattison C, Berquist KR. Dental infection with hepatitis B. JAMA 1975; 232:1231-1233.
64. Campos J, Gonzalez A, Esteban JI, Genesca J, Esteban R, Guardia J. Towards zero risk of posttransfusion hepatitis with 2nd generation antiHCV screening of blood donors (abstract 413). Hepatology 1994; 20: 200A.
65. Henderson DK. Managing occupational risks for hepatitis C transmission in the healthcare setting. Clin Microbiol Rev 2003; 16:546-568.
66. New guidance on hepatitis C infected health care workers. Public Health Laboratory Service, 2002. http://www.phls.org.uk/publications/cdr/archive02/ News/news3402.html#hepC. Accessed November 15, 2002.
67. Robert LM, Bell DM. HIV transmission in the health-care setting. Risks to health-care workers and patients. Infect Dis Clin North Am 1994; 8: 319-329.
68. Seeff LB, Wright EC, Zimmerman HJ, Alter HJ, et al. Type B hepatitis after needlestick exposure: prevention with hepatitis B immune globulin: final report of the Veterans' Administration Cooperative Study. Ann Intern Med 1978; 88:285-293.
69. Werner BJ, Grady GF. Accidental hepatitis-B-surface-antigen-positive inoculations: use of "e" antigen to estimate infectivity. Ann Intern Med 1982; 97:367-369.
70. Henderson DK. Human immunodeficiency virus in the healthcare setting. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York, NY: Elsevier; 2010: in press.
71. Gerberding JL, Littell C, Tarkington A, Brown A, Schecter WP. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N Engl J Med 1990; 322:1788-1793.
72. Gerberding JL, Ramiro N, Perlman J, Rose D. Intraoperative blood exposures at San Francisco General Hospital: provider injuries and patient recontacts. In: Program and abstracts of the 31st Annual Meeting of the Infectious Diseases Society of America; New Orleans, Louisiana; 1993.
73. Gerberding JL, Rose DA, Ramiro NZ, Perlman JL, Schecter WP. Intraoperative provider injuries and potential patient recontacts at San Francisco General Hospital [abstract]. Infect Control Hosp Epidemiol 1994; 15:20.
74. Lowenfels AB, Mehta V, Levi DA, Montecalvo MA, Savino JA,Wormser GP. Reduced frequency of percutaneous injuries in surgeons: 1993 versus 1988. AIDS 1995; 9:199-202.
75. Lowenfels AB, Wormser GP. Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg 1989; 124:1284-1286.
76. Panlilio AL, Foy DR, Edwards JR, et al. Blood contacts during surgical procedures. JAMA 1991; 265:1533-1537.
77. Panlilio AL, Welch BA, Bell DM, et al. Blood and amniotic fluid contact sustained by obstetric personnel during deliveries. Am J Obstet Gynecol 1992; 167:703-708.
78. Popejoy SL, Fry DE. Blood contact and exposure in the operating room. Surg Gynecol Obstet 1991; 172:480-483.
79. Tokars JI, Bell DM, Culver DH, et al. Percutaneous injuries during surgical procedures. JAMA 1992; 267:2899-2904.
80. Elder A, Paterson C. Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices. Occup Med (Lond) 2006; 56:566-574.
81. Sohn S, Eagan J, Sepkowitz KA, Zuccotti G. Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol 2004; 25:536-542.
82. Mendelson MH, Lin-Chen BY, Solomon R, Bailey E, Kogan G, Goldbold J. Evaluation of a safety resheathable winged steel needle for prevention of percutaneous injuries associated with intravascular-access procedures among healthcare workers. Infect Control Hosp Epidemiol 2003; 24:105-112.
83. Alvarado-Ramy F, Beltrami EM, Short LJ, et al. A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993-1995. Infect Control Hosp Epidemiol 2003; 24:97-104.
84. Aarnio P, Laine T. Glove perforation rate in vascular surgery-a comparison between single and double gloving. VASA 2001; 30:122-124.
85. Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures-Minneapolis-St. Paul, New York City, and San Francisco, 1993-1995. MMWR Morb Mortal Wkly Rep 1997; 46:21-25.
86. Centers for Disease Control and Prevention. Evaluation of blunt suture needles in preventing percutaneous injuries among health-care workers during gynecologic surgical procedures-New York City, March 1993- June 1994. MMWR Morb Mortal Wkly Rep 1997; 46:25-29.
87. Tarantola A, Golliot F, L'Heriteau F, et al. Assessment of preventive measures for accidental blood exposure in operating theaters: a survey of 20 hospitals in Northern France. Am J Infect Control 2006; 34:376-382.
88. Wicker S, Jung J, Allwinn R, Gottschalk R, Rabenau HF. Prevalence and prevention of needlestick injuries among health care workers in a German university hospital. Int Arch Occup Environ Health 2008; 81: 347-354.
89. Akduman D, Kim LE, Parks RL, et al. Use of personal protective equipment and operating room behaviors in four surgical subspecialties: personal protective equipment and behaviors in surgery. Infect Control Hosp Epidemiol 1999; 20:110-114.
90. Comer RW, Myers DR, Steadman CD, Carter MJ, Rissing JP, Tedesco FJ. Management considerations for an HIV-positive dental student. J Dent Educ 1991; 55:187-191.
91. Alrawi SJ, Houshan I, Zanial SA, Cunningham JN, Jr., Acinapura AJ, Raju R. Cardiac surgical procedures and glove reinforcements. Heart Surg Forum 2002; 5:66-68.
92. Weber LW. Evaluation of the rate, location, and morphology of perforations in surgical gloves worn in urological operations. Appl Occup Environ Hyg 2003; 18:65-73.
93. Bebbington MW, Treissman MJ. The use of a surgical assist device to reduce glove perforations in postdelivery vaginal repair: a randomized controlled trial. Am J Obstet Gynecol 1996; 175:862-866.
94. Leslie LF, Woods JA, Thacker JG, Morgan RF, McGregor W, Edlich RF. Needle puncture resistance of surgical gloves, finger guards, and glove liners. J Biomed Mater Res 1996; 33:41-46.
95. Salkin JA, Stuchin SA, Kummer FJ, Reininger R. The effectiveness of cut-proof glove liners: cut and puncture resistance, dexterity, and sensibility. Orthopedics 1995; 18:1067-1071.
96. Woods JA, Leslie LF, Drake DB, Edlich RF. Effect of puncture resistant surgical gloves, finger guards, and glove liners on cutaneous sensibility and surgical psychomotor skills. J Biomed Mater Res 1996; 33:47-51.
97. Hartley JE, Ahmed S, Milkins R, Naylor G, Monson JR, Lee PW. Randomized trial of blunt-tipped versus cutting needles to reduce glove puncture during mass closure of the abdomen. Br J Surg 1996; 83:1156-1157.
98. Mingoli A, Sapienza P, Sgarzini G, et al. Influence of blunt needles on surgical glove perforation and safety for the surgeon. Am J Surg 1996; 172:512-516.
99. Wright KU, Moran CG, Briggs PJ. Glove perforation during hip arthroplasty: a randomised prospective study of a new taperpoint needle. J Bone Joint Surg Br 1993; 75:918-920.
100. Bennett NT, Howard RJ. Quantity of blood inoculated in a needlestick injury from suture needles. J Am Coll Surg 1994; 178:107-110.
101. Harpaz R, Van Seidlein L, Averhoff F, et al. Hepatitis B virus transmission associated with cardiothoracic surgery. In: Proceedings of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993; New Orleans, Louisiana: American Society for Microbiology; 1993.
102. Centers for Disease Control and Prevention. Summary and recommendations for preventing transmission of infection with human Tlymphotropic virus type III/lymphadenopathy- associated virus in the workplace. MMWR Morb Mortal Wkly Rep 1985; 34:681-686, 91-95.
103. Gioananni P, Sinicco A, Cariti G, Lucchini A, Paggi G, Giachino O. HIV infection acquired by a nurse. Eur J Epidemiol 1988; 4:119-120.
104. Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med 1991; 90:145-153.
105. Centers for Disease Control and Prevention. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures.MMWR Morb Mortal Wkly Rep 1991; 40:1-9. http://www.cdc.gov/mmwr/preview/mmwrhtml/00014845.htm. Accessed January 8, 2010.
106. Tarantola A, Abiteboul D, Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am J Infect Control 2006; 34:367-375.
107. Sundkvist T, Hamilton GR, Rimmer D, Evans BG, Teo CG. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon. Commun Dis Public Health 1998; 1:48-50.
108. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007; 45:1056-1075.
109. UK Department of Health. Hepatitis C infected health care workers. 2002. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAnduidance/DH-4010554. Accessed January 26, 2009.
110. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006; 130:231-264.
111. Seeff LB, Hoofnagle JH. National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 2002; 36:S1-S2.
112. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39:1147-1171.
113. Alberti A, Boccato S, Vario A, Benvegnu L. Therapy of acute hepatitis C. Hepatology 2002; 36:S195-S200.
114. Jaeckel E, Cornberg M,Wedemeyer H, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345:1452-1457.
115. Wiegand J, Deterding K, Cornberg M, Wedemeyer H. Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother 2008; 62:860-865.
116. Fabris P. Acute hepatitis C: epidemiology, pathogenesis and therapy. Curr Pharm Des 2008; 14:1644-1645.
117. UK Department of Health. HIV Infected Health Care Workers: Guidance on Management and Patient Notification. 2005. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4116415. Accessed January 26, 2009.
118. Tuboku-Metzger J, Chiarello L, Sinkowitz-Cochran RL, Casano-Dickerson A, Cardo D. Public attitudes and opinions toward physicians and dentists infected with bloodborne viruses: results of a national survey. Am J Infect Control 2005; 33:299-303.
119. Closen ML. HIV-AIDS, infected surgeons and dentists, and the medical profession's betrayal of its responsibility to patients. NY Law Sch Law Rev 1996; 41:57-139.
120. DiMaggio SL. State regulations and the HIV-positive health care professional: a response to a problem that does not exist. Am J Law Med 1993; 19:497-522.
121. UK Department of Health. Hepatitis B Infected Health Care Workers: guidance on Implementation of Health Service Circular 2000/020. 2000. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH-4008156. Accessed January 26, 2009.
122. UK Department of Health. Hepatitis B infected healthcare workers and antiviral therapy. 2007. http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-073164. Accessed January 26, 2009.
123. Gunson RN, Shouval D, Roggendorf M, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003; 27:213-230.
124. Buster EH, van der Eijk AA, Schalm SW. Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions. Antiviral Res 2003; 60:79-85.
125. van der Eijk AA, de Man RA, Niesters HG, Schalm SW, Zaaijer HL. Hepatitis B virus (HBV) DNA levels and the management of HBVinfected health care workers. J Viral Hepat 2006; 13:2-4.
126. FitzSimons D, Francois G, De Carli G, et al. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries. Occup Environ Med 2008; 65:446-451.
127. UK Department of Health. Health clearance for tuberculosis, hepatitis B, hepatitis C and HIV: New healthcare workers. 2007. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-073132. Accessed January 26, 2009.
128. Centers for Disease Control and Prevention. Recommendations for prevention of HIV transmission in health-care settings.MMWRMorb Mortal Wkly Rep 1987; 36(Suppl 2):1S-18S.
129. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL. Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003; 24:86-96.
130. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR Morb Mortal Wkly Rep 1986; 35:221-223.
131. Centers for Disease Control and Prevention. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988; 37:377-382.
132. Centers for Disease Control and Prevention. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR Morb Mortal Wkly Rep 1990; 39:1-14.
133. Centers for Disease Control and Prevention, Division of Safety, National Institutes of Health. Occupationally acquired human immunodeficiency virus infections in laboratories producing virus concentrates in large quantities: conclusions and recommendations of an expert team convened by the Director of the National Institutes of Health (NIH). MMWR Morb Mortal Wkly Rep 1988; 37(Suppl 4):19-22.
134. Gross PA, Barrett TI, Dellinger EP, et al. Purpose of quality standards for infectious diseases. Clin Infect Dis 1994; 18:421.
135. The periodic health examination. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J 1979;121:1193-1254.
136. Alter HJ, Seeff LB, Kaplan PM, et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 1976; 295:909-913.
137. Ippolito G, Puro V, Heptonstall J, Jagger J, De Carli G, Petrosillo N. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 1999; 28:365-383.
138. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control 1995; 23:273-277.
139. Bell DM, Shapiro CN, Culver DH, Martone WJ, Curran JW, Hughes JM. Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model. Infect Agents Dis 1992; 1:263-269.
140. Henderson DK, Saah AJ, Zak BJ, et al. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med 1986; 104:644-647.
141. Corden S, Ballard AL, Ijaz S, et al. HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol 2003; 27:52-58.
142. Stringer B, Haines T. Hands-free technique: preventing occupational exposure during surgery. J Perioper Pract 2006; 16:495-500.
143. Buster EH, van der Eijk AA, de Man RA, Janssen HL, Schalm SW. Prolonged antiviral therapy for hepatitis B virus-infected health care workers: a feasible option to prevent work restriction without jeopardizing patient safety. J Viral Hepat 2007; 14:350-354.
144. Stringer B, Infante-Rivard C, Hanley JA. Effectiveness of the hands-free technique in reducing operating theatre injuries. Occup Environ Med 2002; 59:703-707.
145. Nash KL, Bentley I, Hirschfield GM. Managing hepatitis C virus infection. BMJ 2009; 338:b2366.
146. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358(9286):958-965.
147. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347(13):975-982.
148. Gerbert B, Bleecker T, Berlin M, Coates TJ. HIV-infected health care professionals: public opinion about testing, disclosing, and switching. Arch Intern Med 1993; 153:313-320.
149. Gerbert B, Maguire B, Hulley S, Coates T. Physicians and acquired immunodeficiency syndrome: What patients think about human immunodeficiency virus in medical practice. JAMA 1989; 262:1969-1972.
150. American Hospital Association (AHA). Patients' bill of rights. Chicago, IL: AHA; 1975.
151. American Hospital Association (AHA). Management of HIV infection in the hospital. 3rd ed. Chicago, IL: AHA; 1988.
152. American Medical Association (AMA). Current opinions of the Council on Ethical and Judicial Affairs of the American Medical Association. Chicago, IL: AMA; 1986.
153. Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2005; 54:1-17.
154. Centers for Disease Control and Prevention. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Morb Mortal Wkly Rep 2001; 50:1-52.